Bonn, Germany \u2014 Fagron, a global leader in phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adring, announ\u00adced on April 14 that it has acqui\u00adred Hiper\u00adScan, the German market leader in the secure iden\u00adti\u00adfi\u00adca\u00adtion of start\u00ading mate\u00adri\u00adals in phar\u00admacies. High-Tech Gr\u00fcn\u00adder\u00adfonds (HTGF) is selling its shares after having closely supported the team around Dr. Alex\u00adan\u00adder Wolter and Michael Thoma since 2008.<\/p>\n
The Dres\u00adden-based tech\u00adno\u00adlogy company Hiper\u00adScan is a specia\u00adlist in near-infrared (NIR) spec\u00adtro\u00adscopy and emer\u00adged in 2006 as a spin-off from the Fraun\u00adho\u00adfer Insti\u00adtute for Photo\u00adnic Micro\u00adsys\u00adtems (IPMS) to deve\u00adlop inno\u00adva\u00adtive analy\u00adsis systems for phar\u00admacies and other indus\u00adtries. With the Apo-Ident analy\u00adsis system, which is speci\u00adally desi\u00adgned for the iden\u00adti\u00adfi\u00adca\u00adtion of start\u00ading mate\u00adri\u00adals and is used in over 5,500 phar\u00admacies, Hiper\u00adScan has achie\u00adved market leader\u00adship in this segment in Germany and today employs over 50 people.<\/p>\n
Fagron is a global leader in the phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adring of perso\u00adna\u00adli\u00adzed medi\u00adci\u00adnes, focu\u00adsed on provi\u00adding perso\u00adna\u00adli\u00adzed medi\u00adcine to hospi\u00adtals, phar\u00admacies, clinics and pati\u00adents in 35 count\u00adries around the world. Foun\u00added in 1990, the company has over 3,000 employees world\u00adwide. As part of the Fagron family, new markets may open up for Hiper\u00adScan\u2019s tech\u00adno\u00adlogy to further enhance safety and drive the future of perso\u00adna\u00adli\u00adzed medicine.<\/p>\n
\u201cHTGF joined us shortly after we were foun\u00added, which enab\u00adled us to deve\u00adlop Fraun\u00adho\u00adfer IPMS Dres\u00adden\u2019s scan\u00adning grating tech\u00adno\u00adlogy into a market-ready product. Then we gradu\u00adally evol\u00adved from a tech\u00adno\u00adlogy provi\u00adder to an estab\u00adlished provi\u00adder of indus\u00adtry solu\u00adti\u00adons that is now conside\u00adred the gold stan\u00addard in German phar\u00admacies. As part of Fagron, we can help drive the future of perso\u00adna\u00adli\u00adzed medi\u00adcine,\u201d Dr. Alex\u00adan\u00adder Wolter, CEO at HiperScan.<\/p>\n
\u201cI have a special connec\u00adtion with Hiper\u00adScan: On the one hand, the company was my first invest\u00adment in 2008 as a young invest\u00adment mana\u00adger at that time! On the other hand, Hiper\u00adScan is a prime exam\u00adple for seed finan\u00adcing of tech\u00adno\u00adlo\u00adgi\u00adcally very deep compa\u00adnies. This is all the more true since Hiper\u00adScan was foun\u00added with MEMS tech\u00adno\u00adlogy out of the Fraun\u00adho\u00adfer IPMS. With Fagron, Hiper\u00adScan has now found a perfect new owner.\u201d Explains Dr. Andreas Olmes, Prin\u00adci\u00adpal at High-Tech Gr\u00fcnderfonds.<\/p>\n
\u201cWe at Fraun\u00adho\u00adfer Venture first came into cont\u00adact with the Hiper\u00adScan spin-off idea in 2004. Mana\u00adging Direc\u00adtor Alex\u00adan\u00adder Wolter was among the first parti\u00adci\u00adpants in a now estab\u00adlished educa\u00adtio\u00adnal measure for pros\u00adpec\u00adtive foun\u00adders. At the same time, the Hiper\u00adScan spin-off idea was supported by the prede\u00adces\u00adsor program of the current AHEAD program and recei\u00adved further inter\u00adnal funding after its foun\u00adda\u00adtion with the goal of manage\u00adment expan\u00adsion.\u201d Manfred St\u00f6ger, Invest\u00adment Mana\u00adger at Fraun\u00adho\u00adfer Venture.<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Bonn, Germany \u2014 Fagron, a global leader in phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adring, announ\u00adced on April 14 that it has acqui\u00adred Hiper\u00adScan, the German market leader in the secure iden\u00adti\u00adfi\u00adca\u00adtion of start\u00ading mate\u00adri\u00adals in phar\u00admacies. High-Tech Gr\u00fcn\u00adder\u00adfonds (HTGF) is selling its shares after having closely supported the team around Dr. Alex\u00adan\u00adder Wolter and Michael Thoma since 2008. The Dresden-based [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":39733,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1373],"tags":[],"class_list":["post-39938","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-venture-capital-en"],"yoast_head":"\n